Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising RUNX3 protein and CDK4 inhibitor or mTOR inhibitor cotreatment for prevention or treatment of cancer

Pharmaceutical composition comprising RUNX3 protein and CDK4 inhibitor or mTOR inhibitor cotreatment for prevention or treatment of cancer

US Patent 12414980 · Granted Sep 16, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and system for health monitoring of collaborative robot2025
Method for preparing supported metallocene catalyst, supported metallocene catal2025
Data management method and device for diagnosing defect of collaborative robot2025
Method and apparatus for transmitting and receiving control information in wirel2025
Method for producing metallocene-supported catalyst and metallocene-supported ca2025
Module attach/detach rack apparatus for module type control and monitoring syste2025
V2X-based electronic toll collection system and method2025
Dodecyl sulfate-doped poly(3,4-ethylenedioxythiophene) film and manufacturing me2024
Hybrid supported metallocene catalyst and process for preparing polyethylene cop2024
Transition metal compound and catalyst composition comprising the same2024
Propylene-ethylene random copolymer2024
Multilayer electronic component with conductive resin layer2024